Is it Possible to Estimate the Effect of Risedronat Treatment on Bone Mineral Density in Postmenapausal Osteoporosis by Biochemical Marker? - Original Investigation
In this study we aimed to evaluate and compare the effects of risedronate on bone mineral density (BMD) and biochemical markers in postmenopausal osteoporosis. One hundred three patients with postmenopausal osteoporosis were included in the study. The patients were divided into two groups as group...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2006-12-01
|
Series: | Türk Osteoporoz Dergisi |
Subjects: | |
Online Access: | http://www.turkosteoporozdergisi.org/article_4144/Is-It-Possible-To-Estimate-The-Effect-Of-Risedronat-Treatment-On-Bone-Mineraldensity-In-Postmenapausal-Osteoporosis-By-Biochemical-Marker-Original-Investigation |